Canadian families waiting for neurodevelopmental assessments and services often face wait times stretching months to years. During this period, most families receive little to no guidance on how to support their child’s development or navigate the care system. This gap disproportionately affects families in rural, remote, and underserved communities, and for children with neurodevelopmental disabilities, it means critical developmental windows pass without support.

BRIDGES OS is a clinician-designed digital platform, built by NeuroAI, that provides families with structured, evidence-informed support from the point of referral onward, not just when an appointment becomes available. Through a mobile application, families access a conversational AI coaching companion, developmental questionnaires, and curated clinical resources. For clinicians, a secure identity layer called AllieID allows a child’s developmental information to follow them across care settings, reducing duplicated intake and supporting more informed clinical encounters. The platform is privacy-by-design, with all data stored on Canadian infrastructure and governed by applicable federal and provincial privacy legislation.

This project will implement and evaluate BRIDGES across pilot sites within the Canadian public healthcare system, with multilingual support in English and French. Aligned with the principles of the federal Connected Care for Canadians Act (Bill S-5), BRIDGES is designed so that health information follows families across providers and jurisdictions. The project will deliver a replication-ready implementation kit for adoption by additional hospitals and provincial programs across Canada.

 

Award

  • Kids Brain Health Network: $108,998

Team

  • Chief Executive Officer: Asif Hasan
  • Chief Medical Officer, NeuroAI and Developmental Pediatrician, Holland Bloorview Kids Rehabilitation Hospital: Dr. Rageen Rajendram
  • Chief Operations Officer: Brad Wasson

About NeuroAI

NeuroAI is a mission-driven healthtech startup founded in 2023 in Fredericton, New Brunswick, that aims to transform neurodevelopmental care by combining advanced artificial intelligence with deep clinical expertise. The company addresses systemic inefficiencies, such as long diagnostic waitlists that often span 12 to 18 months, through its core product, BRIDGES OS, a modular platform designed to seamlessly connect families, clinicians, and institutions.

This ecosystem consists of two primary solutions: BRIDGES Clarity, which streamlines workflows and decision-making for healthcare providers, and BRIDGES Engage, a caregiver-focused tool providing personalized intervention strategies and educational resources. Central to the platform is BRIDGES Allie, an AI-powered coach that delivers tailored insights and facilitates data-driven care across home and clinical settings. By fostering collaboration and providing immediate, actionable resources, NeuroAI seeks to ensure that no family navigates the journey of neurodevelopmental challenges alone while simultaneously optimizing institutional efficiency.